The Oncology Institute Stock Analysis
TOIIW Stock | USD 0.03 0 9.80% |
The Oncology Institute is overvalued with Real Value of 0.0214 and Hype Value of 0.03. The main objective of Oncology Institute stock analysis is to determine its intrinsic value, which is an estimate of what The Oncology Institute is worth, separate from its market price. There are two main types of Oncology Institute's stock analysis: fundamental analysis and technical analysis.
The Oncology Institute stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Oncology Institute is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Oncology Stock trading window is adjusted to America/New York timezone.
Oncology |
Oncology Stock Analysis Notes
The company recorded a loss per share of 602.09. The Oncology Institute had not issued any dividends in recent years. The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. The company was founded in 2007 and is based in Cerritos, California. Oncology Institute operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 553 people. To find out more about The Oncology Institute contact FACHE MBA at 562 735 3226 or learn more at https://theoncologyinstitute.com.Oncology Institute Quarterly Total Revenue |
|
The Oncology Institute Investment Alerts
Oncology Institute is way too risky over 90 days horizon | |
Oncology Institute has some characteristics of a very speculative penny stock | |
Oncology Institute appears to be risky and price may revert if volatility continues | |
The company reported the revenue of 324.24 M. Net Loss for the year was (83.07 M) with profit before overhead, payroll, taxes, and interest of 53.74 M. | |
The Oncology Institute has accumulated about 15.17 M in cash with (36.31 M) of positive cash flow from operations. | |
Latest headline from news.google.com: The Oncology Institute Reports Q4 and Full Year 2024 Financial Results with Significant Revenue Growth and Operational Improvements - Nasdaq |
Oncology Institute Thematic Classifications
In addition to having Oncology Institute stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
![]() | HealthcareUSA Equities from Healthcare industry as classified by Fama & French |
Oncology Profitablity
The company has Profit Margin (PM) of (0.19) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.14) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.14.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.52) | (0.49) | |
Return On Capital Employed | (0.51) | (0.53) | |
Return On Assets | (0.46) | (0.43) | |
Return On Equity | (1.68) | (1.59) |
Management Efficiency
The company has return on total asset (ROA) of (0.2) % which means that it has lost $0.2 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.6085) %, meaning that it generated substantial loss on money invested by shareholders. Oncology Institute's management efficiency ratios could be used to measure how well Oncology Institute manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to climb to -0.49 in 2025. Return On Capital Employed is likely to drop to -0.53 in 2025. At this time, Oncology Institute's Other Current Assets are fairly stable compared to the past year. Debt To Assets is likely to climb to 0.54 in 2025, whereas Non Current Assets Total are likely to drop slightly above 70.9 M in 2025.Last Reported | Projected for Next Year | ||
Book Value Per Share | 0.70 | 0.83 | |
Tangible Book Value Per Share | 0.43 | 0.39 | |
Enterprise Value Over EBITDA | (3.86) | (3.67) | |
Price Book Value Ratio | 3.03 | 2.88 | |
Price Fair Value | 3.03 | 2.88 | |
Enterprise Value Multiple | (3.86) | (3.67) | |
Enterprise Value | 272.1 M | 494.9 M |
The operational strategies employed by Oncology Institute management play a crucial role in its market positioning. Assessing these strategies alongside financial data helps us evaluate the stock's investment potential.
Technical Drivers
As of the 25th of March, Oncology Institute holds the Semi Deviation of 13.54, coefficient of variation of 684.8, and Market Risk Adjusted Performance of 2.77. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Oncology Institute, as well as the relationship between them. Please check The Oncology Institute semi deviation, jensen alpha, as well as the relationship between the Jensen Alpha and semi variance to decide if The Oncology Institute is priced some-what accurately, providing market reflects its current price of 0.0269 per share. As The Oncology Institute appears to be a penny stock we also advise to check out its total risk alpha numbers.The Oncology Institute Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Oncology Institute middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for The Oncology Institute. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
The Oncology Institute Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Oncology Institute insiders, such as employees or executives, is commonly permitted as long as it does not rely on Oncology Institute's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Oncology Institute insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Oncology Institute Predictive Daily Indicators
Oncology Institute intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Oncology Institute stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Oncology Institute Forecast Models
Oncology Institute's time-series forecasting models are one of many Oncology Institute's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Oncology Institute's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Oncology Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Oncology Institute prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Oncology shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Oncology Institute. By using and applying Oncology Stock analysis, traders can create a robust methodology for identifying Oncology entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (0.16) | (0.17) | |
Operating Profit Margin | (0.15) | (0.16) | |
Net Loss | (0.16) | (0.17) | |
Gross Profit Margin | 0.21 | 0.22 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Oncology Institute to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Anywhere Now
Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device |
All Next | Launch Module |
Additional Tools for Oncology Stock Analysis
When running Oncology Institute's price analysis, check to measure Oncology Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncology Institute is operating at the current time. Most of Oncology Institute's value examination focuses on studying past and present price action to predict the probability of Oncology Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncology Institute's price. Additionally, you may evaluate how the addition of Oncology Institute to your portfolios can decrease your overall portfolio volatility.